SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-055242
Filing Date
2014-02-14
Accepted
2014-02-14 17:23:59
Documents
1
Group Members
HEALTHCAP IV BIS, L.P.HEALTHCAP IV, K.B.OFCO CLUB IV

Document Format Files

Seq Description Document Type Size
1 SC 13G d676514dsc13g.htm SC 13G 123490
  Complete submission text file 0001193125-14-055242.txt   124817
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87623 | Film No.: 14619300
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 18 AVENUE DOUCHY CH1006 LAUSANNE V8 00000
HEALTHCAP IV LP (Filed by) CIK: 0001178496 (see all company filings)

IRS No.: 000000000
Type: SC 13G